الخميس 10 محرم 1448هـ
جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa
جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa
| عنوان الدراسة | داعم الدراسة | حالة الدراسة | دواء الدراسة | مرحلة الدراسة | رقم بروتوكول الدراسة | موقع الدراسة |
|---|---|---|---|---|---|---|
| The Influence of a rapid relief of gastro esophageal reflux disease (GERD) symptoms on the quality of life and patient satisfaction after initiating treatment with a Proton Pump Inhibitor. | Sanofi | Ongoing | N/A | 4 | DRIEG_L_05705 | University District Hospital (Jeddah) |
| An observational registry improving Control of Hypertension and Achieving Normalization Goal Earlier | Sanofi | Ongoing | N/A | 4 | DIREG_L_05059 | Erfan & Bagedo General Hospital (Jeddah) |
| An observational study to monitor the efficacy and tolerability of levofloxacin 250 mg OD for treatment of simple lower UTI in Saudi Arabia | Sanofi | Ongoing | Levofloxacin | 4 | LEVOF_L_05172 | Erfan & Bagedo General Hospital (Jeddah) |
| International Diabetes Management Practices Study (Wave 5) | Sanofi | Ongoing | N/A | 4 | DIREG_R_05941 | King Fahad Hospital (Jeddah) |
| A randomized, double-blind, placebo-controlled phase II study to investigate the efficacy and safety of riociguat (0.5 mg, 1.0 mg, 1.5 mg, 2.0 mg and 2.5 mg TID) in patients with symptomatic pulmonary hypertension associated with idiopathic interstitial pneumonias (IIP). | Bayer | Completed | Riociguat | 2 | BAY 63-2521 / 13605 | King Fahad Medical City (Riyadh), King Khalid University Hospital (Riyadh) |
| The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma orOcular Hypertension. | Allergan | Ongoing | Bimatoprost SR | 3 | 192024-092 | King Khaled Eye Specialist Hospital (Riyadh), King Abdullah Medical City (Makkah) |
| Tracking Biologics Along the Silk Road | Janssen-Cilag International NV | Ongoing | Infliximab / Golimumab / Ustekinumab | 4 | C0168ARA40 | King Khalid University Hospital (Riyadh) |
| Efficacy and Safety Assessment of NIlotinib in Chronic Myeloid Leukemia (CML) Patients with Suboptimal Response on Imatinib Therapy (NISRI) | KAIMRC | Ongoing | NILOTINIB | 4 | RC12/052/R | King Abdulaziz Medical City NG (Riyadh), King Fahad Specialist Hospital (Dammam) |
| Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers, An International, Multicenter, Double Blind, Randomized Placebo Controlled Phase 3 trial (ICR-02/ASCOLT) | King Fahad Medical City | Ongoing | Aspirin | 3 | ICR-02/ASCOLT | King Fahad Medical City (Riyadh) |
| A study of the factors predicting radiation exposure to contacts of Saudi patients treated with radioactive iodine (I 131): A preliminary study for patients’ criteria selection for possible high dose I131 therapy on out-patient basis in the future | King Abdulaziz City for Science and Technology (KACST) | Completed | 131 Iodine | 4 | (version#1) dated 10-Apr-14 | King Abdullah Medical City (Makkah) |
تاريخ آخر تحديث: 08/05/2025 بتمام الساعة 03:17 مساء بتوقيت المملكة العربية السعودية
لم يتم تقديم أي تقييمات لهذه الصفحة بعد.
التعليقات والاقتراحات
لأي استفسارات أو ملاحظات حول الخدمات الحكومية، يرجى تعبئة المعلومات المطلوبة.